Literature DB >> 29197854

Nivolumab-induced polyarthritis.

Shoko Kodama1, Koji Kurose2, Tomoyuki Mukai1, Yoshitaka Morita1.   

Abstract

Entities:  

Keywords:  drugs: musculoskeletal and joint diseases; musculoskeletal syndromes

Mesh:

Substances:

Year:  2017        PMID: 29197854      PMCID: PMC5720308          DOI: 10.1136/bcr-2017-223387

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


× No keyword cloud information.
  1 in total

Review 1.  Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?

Authors:  Michiel van der Vlist; Jurgen Kuball; Timothy R D Radstake; Linde Meyaard
Journal:  Nat Rev Rheumatol       Date:  2016-08-19       Impact factor: 20.543

  1 in total
  3 in total

1.  Immunotherapy-Induced Eosinophilic Tracheitis.

Authors:  Eduardo Tellez-Garcia; Alejandra Valdivia Padilla; Horiana Grosu
Journal:  Cureus       Date:  2022-04-13

2.  Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy.

Authors:  Noha Abdel-Wahab; Maria E Suarez-Almazor
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

3.  Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy.

Authors:  Shintaro Yamamoto; Shunichi Fujita; Tomoyuki Mukai; Hiroshi Sawachika; Yoshitaka Morita
Journal:  Intern Med       Date:  2019-10-31       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.